Traditional Chinese Medicine Compound Preparations Are Associated with Low Disease-Related Complication Rates in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study of 11,074 Patients
Table 1
Baseline characteristics of TCMCP and non-TCMCP patients, matched and unmatched by propensity score.
Before matching
After matching
Total ()
TCMCP ()
Non-TCMCP ()
value
Total ()
TCMCP ()
Non-TCMCP ()
value
Age (year)
10.649
0.001
3.395
0.065
<57
4643 (50.6%)
1879 (48.6%)
2764 (52.0%)
3223 (45.8%)
1650 (46.9%)
1573 (44.7%)
≥57
4540 (49.4%)
1990 (51.4%)
2550 (48.0%)
3811 (54.2%)
1867 (53.1%)
1944 (55.3%)
Sex
55.078
<0.001
1.164
0.281
Female
7534 (82.0%)
3039 (78.5%)
4494 (84.6%)
5923 (84.2%)
2945 (83.7%)
2978 (84.7%)
Male
1650 (18.0%)
830 (21.5%)
820 (15.4%)
1111 (15.8%)
572 (16.3%)
539 (15.3%)
Underlying diseases
Hypertension
2804 (30.5%)
988 (25.5%)
1816 (34.2%)
78.751
<0.001
2111 (30.0%)
1072 (30.5%)
1039 (29.5%)
0.737
0.391
Diabetes
903 (9.8%)
422 (10.9%)
481 (12.4%)
8.695
0.003
647 (9.20%)
315 (8.96%)
332 (9.44%)
0.492
0.483
Hyperlipidemia
250 (2.7%)
99 (2.6%)
151 (2.8%)
0.676
0.411
179 (2.54%)
85 (2.42%)
94 (2.67%)
0.464
0.496
Treatment
cDMARDs
6276 (68.3%)
2697 (69.7%)
3579 (67.4%)
5.752
0.016
4968 (70.6%)
2507 (71.3%)
2461 (70.0%)
1.450
0.229
Corticosteroid
5597 (60.9%)
2191 (56.6%)
3406 (64.1%)
52.423
<0.001
4291 (61.0%)
2117 (60.2%)
2174 (61.8%)
1.942
0.163
Note: TCMCP: users of traditional Chinese medicine compound preparation; non-TCMCP: nonusers of traditional Chinese medicine compound preparation.
